Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal

January 18, 2017


Pharmatest Services Ltd attends the Tumor Models conference in San Francisco, CA, on January 24 – 26. Pharmatest is sponsoring the conference and holds a scientific oral presentation and poster presentation in the event.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. The Tumor models event is organized by Hanson Wade for the first time in San Francisco. It focuses on increasing the value of preclinical and translational research.

Pharmatest has a booth and the following scientific presentations in the event:

-       Poster presentation in the poster session starting on January 25 at 3.35 pm titled “Validation of human osteoclast cultures for studying mode-of-action and identification of new compounds with the potential of inhibiting the vicious cycle in osteolytic bone metastases".

-       Oral presentation by Mari Suominen, the cancer research director of Pharmatest, on January 26 at 10.05 am titled “Rationale for testing anti-cancer drug efficacy in the bone microenvironment”.

Handout of the poster presentation will be available in a link above after the start of the poster session.

If you would like to schedule a meeting with our representatives during the conference, click here.